FDA approves Merck's Premyvis letermovir for CMV

By Allison Johnson | Nov 10, 2017 | 8:44 PM GMT

FDA approved once-daily oral and IV formulations of Prevymis letermovir (MK-8228) from Merck & Co.

Read the full 154 word article

How to gain access

Continue reading with a
two-week free trial.